![1-Piperidinecarboxamide,4-[2-[4-[(11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]- structure, CAS 193275-84-2](/structures/80000/68403_1_193275_84_2.png)
CAS Number193275-84-2
Synonyms1-PiperidinecarboxaMide,4-[2-[4-[(11R)-3,10-dibroMo-8-chloro-6; Lonafarnib; LonafarMib; Lonafarnib [usan]; Sarasar
Molecular FormulaC27H31Br2ClN4O2
Molecular Weight638.82
Purity≥98 (HPLC)%
Density1.5±0.1 g/cm3
Boiling Point710.4±70.0 °C at 760 mmHg
Melting Point214.5-215.9° (monohydrate); mp 222-223°
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 193275-84-2 |
| Catalog No. | 2A-9068403 |
| Chinese Name | 氯那法尼 |
| Synonyms | 1-PiperidinecarboxaMide,4-[2-[4-[(11R)-3,10-dibroMo-8-chloro-6; Lonafarnib; LonafarMib; Lonafarnib [usan]; Sarasar |
| Molecular Formula | C27H31Br2ClN4O2 |
| Molecular Weight | 638.82 |
| Purity | ≥98 (HPLC) |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 710.4±70.0 °C at 760 mmHg |
| Melting Point | 214.5-215.9° (monohydrate); mp 222-223° |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | Lonafarnib is an orally active farnesyl protein transferase (FPTase) inhibitor against H-ras, K-ras and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM respectively. |
| PubChem ID | 329825894 |
| MDL Number | MFCD06795138 |
| SMILES | O=C(N)N(CC1)CCC1CC(N2CCC([C@H]3C(N=CC(Br)=C4)=C4CCC5=C3C(Br)=CC(Cl)=C5)CC2)=O |
| InChI | 1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1 |
| InChI Key | DHMTURDWPRKSOA-RUZDIDTESA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/68403_1_193275_84_2.pdf |
| Transport Info | Product Name: Lonafarni |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| N-Boc-3-piperidineaceticacid | 183483-09-2 | 2A-9068283 |
| 4-(2-Aminoethyl)-1-Boc-piperidine | 146093-46-1 | 2A-9068285 |
| (R)-(-)-1-Benzyl-3-(methylamino)pyrrolidine | 144043-17-4 | 2A-9068331 |
| (2R,3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-2-bromo-6-(3-phenylpropyl)tetrahydro-2H-pyran | 4196-35-4 | 2A-9068396 |
| 8-Bromo-1,2,3,4-tetrahydro-[1,6]naphthyridine | 362606-16-4 | 2A-9068397 |
| 5-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylicacid | 165947-48-8 | 2A-9068413 |
| 5,8-dibromo-[1,2,4]triazolo[1,5-a]pyrazine | 959755-46-5 | 2A-9068417 |
| ethyl4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate | 1186189-28-5 | 2A-9068454 |
| ethyl4-hydroxy-1-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate | 77276-17-6 | 2A-9068455 |
| ethyl4-hydroxy-1-isopropyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate | 1253790-69-0 | 2A-9068456 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA